Bio Therapeutic Drugs Company Investment Opportunity in Gurgaon, India

Cancer immunotherapy based research & medicine manufacturing company based out of Gurgaon.
This Business is on a Premium Plan
Established From
Employees
Legal Entity
Reported Sales
Run Rate Sales
USD 250 thousand
EBITDA Margin
20 - 30 %
Locations
Local Time
2:52 PM New Delhi
Listed By
Management Member
Status
Responsive
Overall Rating
Seeking Investment
USD 17 million for 26.0% stake (Native Currency: INR 1,200,000,000)
Reason: Immediate Term: - The company intends to set up a 35,000 ft2 laboratory to manufacture 120,000 dose... View More
Includes physical assets worth USD 360 thousand
Name, Phone, Email
Available after connect
Business Name
Available after connect
User Verification
Business Overview

- Business came into existence in the year 2010 with a vision to find the roots of cancer and to improve the quality of life by immunology based Dendritic cell-based therapy.

- Company aims to provide an economical and effective method of DC immunotherapy in India.

- We received the Indian FDA approval to manufacture / market immunotherapy treatment-related medicines for cancer in India in Dec 2017. We started selling medicines from April 2018.

- Tie-ups with various hospitals, oncologists and Government health schemes for the supply of products in Delhi NCR region.

- We prepare custom-made medicine for each & every patient. So the production number depends upon the requirements from customers.

- Company launched Phase II clinical trials across 7 hospitals in India where it treated 51 patients.

- We have the capacity to treat 600 patients on an annual basis. The company was conferred with the Excellence award for DC clinical trial at UAE Cancer Congress at Dubai.

- Company would start making profits in the near future. Last our sales was only from the research work. This year sale of medicines too helped in revenue generation. We will continue to see this improving.

- Promoter1: A visionary entrepreneur, responsible for developing dendritic cell immunotherapy at a commercial scale in India.

- Promoter2: A first generation entrepreneur responsible for bringing the cellular therapies in India.

Products & Services Overview

- Developed a unique patented technology to load antigen on Dendritic Cells matured from a patient's own monocytes.

- Filed another patent in June 2017 to decrease the effects of an inhibitory molecule.

Facilities Overview
Recent Activity
  • 2 weeks ago
    CEO, Chennai, Financial Advisor connected with this business
Tags:

Invest in Gurgaon, India

,

Invest in Bio Therapeutic Drugs Company

,

Investment Opportunity in Gurgaon, India

,

Bio Therapeutic Drugs Company Investment Opportunity

,

Invest in Bio Therapeutic Drugs Company in Gurgaon, India

,

Bio Therapeutic Drugs Company Investment Opportunity in Gurgaon, India

Disclaimer: SMERGERS is a marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
Contact Business
Disclaimer: SMERGERS is a marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct.
You might also be interested in these businesses

Frequently
Asked
Questions

  • Why can’t I see the business’ name or contact number? How do I contact the business?

    All business profiles on SMERGERS are displayed on a “no name” basis to protect the confidentiality of the business. You can register as an investor, acquirer, lender or advisor on SMERGERS and express your interest to connect with any business. Most businesses choose to disclose these details after such an introduction is made. Some businesses may request you to sign a Non-Disclosure Agreement before revealing further details. To register and connect with businesses click here. Alternatively, you could shortlist businesses from here, click on "Contact Business" and fill in your details on the right hand side. 

  • What level of due diligence does SMERGERS conduct on the businesses/member?

    SMERGERS scrutinizes all profiles and only features a select group of businesses, investors, advisors that meet a basic requirement. When required, certain members may have submitted some form of proof before their profile is approved on the website and this is not shared with other users. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. SMERGERS is a marketplace for connecting business sell sides with investors, buyers, lenders and advisors and neither SMERGERS represents nor guarantees that the information mentioned on the profile is complete or correct.

  • How can I be sure that the business profile will be active?
    We regularly filter out businesses which are inactive or have already closed a transaction. Typically, if the business is actively looking to sell/raise capital, the status is shown in green.
  • How does SMERGERS rate business profiles?
    SMERGERS compares financial metrics of each business with various other private and publicly listed businesses from the same industry. SMERGERS also considers profile completeness, activity, trust level among members, and additional parameters to arrive at a composite score to rate business profiles. SMERGERS Rating is only meant to help investors/acquirers/lenders select businesses which they would like to connect with. Members need to conduct their own due diligence before entering into any form of transaction with the business.
  • Do I need to pay to connect with a business?
    The first two introductions are free, post that you will need to subscribe to one of our member plans. There are no other charges if you close a transaction. We offer enterprise plans for financial institutions such as Banks, PE, VC, and Funds. Contact us if you want to know more.
  • Show more